X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (27) 27
Journal Article (24) 24
Magazine Article (16) 16
Book Review (11) 11
Publication (7) 7
Book / eBook (1) 1
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (6) 6
humans (6) 6
index medicus (6) 6
middle aged (6) 6
adult (5) 5
female (5) 5
male (5) 5
multiple myeloma - drug therapy (5) 5
abridged index medicus (4) 4
bortezomib (4) 4
clinical trials and observations (4) 4
hematology (4) 4
aged, 80 and over (3) 3
article (3) 3
cell biology (3) 3
lymphoid neoplasia (3) 3
oligopeptides - therapeutic use (3) 3
therapy (3) 3
treatment outcome (3) 3
actin (2) 2
actin depolymerizing factors (2) 2
actins - metabolism (2) 2
animals (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
baseball (2) 2
binding sites (2) 2
boronic acids - administration & dosage (2) 2
boronic acids - therapeutic use (2) 2
capping protein (2) 2
cells (2) 2
destrin (2) 2
disease-free survival (2) 2
drug resistance, neoplasm (2) 2
impact (2) 2
in-vivo (2) 2
irreversible inhibitor (2) 2
macromolecular substances (2) 2
management (2) 2
microfilament proteins - genetics (2) 2
microfilament proteins - metabolism (2) 2
oligopeptides - adverse effects (2) 2
peripheral neuropathy (2) 2
pr-171 (2) 2
proteins (2) 2
pyrazines - administration & dosage (2) 2
pyrazines - therapeutic use (2) 2
recurrence (2) 2
site planning (2) 2
survival rate (2) 2
thalidomide - administration & dosage (2) 2
thalidomide - adverse effects (2) 2
thalidomide - analogs & derivatives (2) 2
twinfilin (2) 2
yeast (2) 2
1915 (1) 1
1915-2010 (1) 1
327.01 (1) 1
acanthamoeba-profilin (1) 1
accelerated heavy-particles (1) 1
actin cytoskeleton - metabolism (1) 1
actin-depolymerizing factor (1) 1
actin; twinfilin; capping protein; pip2; budding yeast (1) 1
actins (1) 1
actins - physiology (1) 1
adaptability (1) 1
adapted therapy msmart (1) 1
addresses, essays, lectures (1) 1
adenosine diphosphate - analogs & derivatives (1) 1
adenosine diphosphate - metabolism (1) 1
adenosine diphosphate - physiology (1) 1
adp-actin (1) 1
age (1) 1
amino acid motifs (1) 1
amino acid sequence (1) 1
analysis (1) 1
animals, genetically modified (1) 1
antibiotics, antineoplastic - administration & dosage (1) 1
antibiotics, antineoplastic - adverse effects (1) 1
antibodies (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents, hormonal - administration & dosage (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
applications (1) 1
arts & entertainment (1) 1
arts festivals (1) 1
astronauts (1) 1
aufsatzsammlung (1) 1
automobile drivers (1) 1
barbed-end (1) 1
base sequence (1) 1
basic helix-loop-helix transcription factors - genetics (1) 1
basic helix-loop-helix transcription factors - metabolism (1) 1
beaver dam eye (1) 1
bicycling (1) 1
binding sites - genetics (1) 1
biochemistry & molecular biology (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 2013, Volume 121, Issue 11, pp. 1961 - 1967
Journal Article
Journal Article
Journal Article
TCA Regional News, 09/2016
Newspaper Article
Blood, ISSN 0006-4971, 07/2011, Volume 118, Issue 3, pp. 535 - 543
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 1875 - 1875
Abstract Abstract 1875 Introduction: Carfilzomib (CFZ) is a next-generation proteasome inhibitor that has demonstrated durable single-agent antitumor activity... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 480 - 480
Abstract Abstract 480 Introduction: Vorinostat (VOR), an oral inhibitor of histone deacetylase (HDAC) class I and class II proteins, affects pathways... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 813 - 813
Abstract Abstract 813FN2 Introduction: Carfilzomib is a next-generation proteasome inhibitor that selectively and irreversibly binds to its target, resulting... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 631 - 631
Abstract Abstract 631 Introduction: In relapsed and/or refractory MM, the combination of carfilzomib (CFZ) with lenalidomide (Len), and low-dose dexamethasone... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 302 - 302
Abstract Abstract 302 Background: Marizomib has a novel, non-peptide based, bicyclic structure and compared to other proteasome inhibitors, unique properties... 
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 1937 - 1937
Abstract Abstract 1937 Background: Three-drug combinations with bortezomib (Bz) and/or either thalidomide or lenalidomide (Len) are highly active in frontline... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 1024 - 1024
Abstract Abstract 1024 Background: The MMRC is a non-profit, disease-focused consortium founded in 2004. Sixteen North American member institutions with... 
Journal Article